TREA

86848704 - AJOYA

Follow

Information

  • Trademark
  • 86848704
  • Serial Number
    86848704
  • Filing Date
    December 14, 2015
    8 years ago
  • Transaction Date
    February 20, 2020
    4 years ago
  • Status Date
    March 04, 2019
    5 years ago
  • Published for Opposition Date
    May 31, 2016
    8 years ago
  • Location Date
    June 24, 2017
    7 years ago
  • Status Code
    606
  • Current Location
    INTENT TO USE SECTION
    Employee Name
    VIGIL, JACOB EUGENE
  • Attorney Name
    Matthew O. Brady
    Law Office Assigned Location Code
    M40
  • Owners
Information
Mark Drawing Code
4000
Mark Identification
AJOYA
Case File Statements
  • GS0051: Oral, transdermal, injectable and intravaginal contraceptive preparations; intravaginal contraceptive sponge; Hormone replacement therapy preparations; Pharmaceutical preparations for the prevention of preterm birth or pregnancy; Pharmaceutical preparations for the treatment and prevention of urinary incontinence and overactive bladder; Pharmaceutical preparations for the treatment and prevention of iron deficiency and anemia; Pharmaceutical preparations for the treatment and prevention of osteoporosis; Pharmaceutical preparations for the treatment and prevention of endometriosis; Pharmaceutical preparations for the treatment and prevention of symptoms associated with uterine fibroids; Iron chelating pharmaceutical preparations; Fertility enhancing preparations; Pharmaceuticals and medicines for the treatment and prevention of sexual dysfunction; Pharmaceuticals and medicines affecting sensory organs; Pharmaceuticals and medicines affecting the central nervous system; Pharmaceuticals and medicines affecting urogenital organs; Pharmaceuticals and medicines affecting circulatory systems; Pharmaceuticals and medicines for the treatment of cardiovascular and blood pressure diseases and disorders; Pharmaceutical preparations for the treatment and prevention of digestive tract, gastrointestinal and dermatological diseases and disorders; Pharmaceuticals and medicines for the treatment and prevention of irritable bowel syndrome; Pharmaceutical preparations that support, encourage or promote bone strength or bone health or which are used in the treatment of bone disorders or bone diseases; Antibiotics; Antifungal preparations; Antivirals and Antiprotozoals; Pharmaceutical preparations for the prevention and treatment of bacterial infections; Pharmaceutical preparations for the prevention and treatment of diabetes and diabetic neuropathy; Pharmaceutical preparations for the prevention and treatment of pain and neuropathic pain; Pharmaceutical preparations for the prevention and treatment of respiratory system diseases and disorders; Pharmaceutical preparations for the prevention and treatment of neurological diseases and disorders; Pharmaceutical preparations for the prevention and treatment of neurodegenerative diseases and disorders; Pharmaceutical preparations for the prevention and treatment of peripheral nervous system diseases and disorders; Pharmaceutical preparations for the prevention and treatment of hypertension; Pharmaceutical preparations for the prevention and treatment of Alzheimer's disease, dementia, AIDS-related dementia, CNS, neurological disorders, neurodegenerative disorders, and depression; Pharmaceuticals, namely, neuroprotective agents; antidepressants; pharmaceuticals, namely, antipsychotics; coronary vasodilating agents; Pharmaceutical preparations for the treatment of hypothyroidism; Pharmaceutical preparations for skin care used in connection with anti-aging, the treatment of glabellar lines, facial wrinkles, asymmetries and defects and conditions of the human skin, facial aesthetic surgery, facial aesthetic reconstruction, breast aesthetics; topical antibiotics, anti-inflammatories, anti-infectives, anti-glaucoma eye drops and decongestant formulations; sterile ointments for medical use; ocular wetting solutions, artificial tears and pharmaceutical preparations for the treatment of minor ocular inflammations and allergic conditions; Pharmaceutical preparations for the treatment of neurological disorders, muscle dystonias, smooth muscle disorders, autonomic nerve disorders, headaches, hyperhydrosis, sports injuries, cerebral palsy, spasms, tremors and pain; dermatological formulations, namely, medicated dry skin lotions and creams, acne medications and medicated skin lighteners; Pharmaceuticals and cosmeceuticals, namely, medicated skin cleansers, toners, moisturizers, skin rejuvenators, rehydrating creams, and lotions for the face and body
Case File Event Statements
  • 2/19/2020 - 4 years ago
    36 - ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY Type: ASCK
  • 3/4/2019 - 5 years ago
    35 - ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED Type: MAB6
  • 3/4/2019 - 5 years ago
    34 - ABANDONMENT - NO USE STATEMENT FILED Type: ABN6
  • 7/18/2018 - 6 years ago
    33 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA
  • 7/16/2018 - 6 years ago
    32 - EXTENSION 4 GRANTED Type: EX4G
  • 7/16/2018 - 6 years ago
    31 - EXTENSION 4 FILED Type: EXT4
  • 7/16/2018 - 6 years ago
    30 - TEAS EXTENSION RECEIVED Type: EEXT
  • 12/12/2017 - 6 years ago
    29 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA
  • 12/8/2017 - 6 years ago
    28 - EXTENSION 3 GRANTED Type: EX3G
  • 12/8/2017 - 6 years ago
    27 - EXTENSION 3 FILED Type: EXT3
  • 12/8/2017 - 6 years ago
    26 - TEAS EXTENSION RECEIVED Type: EEXT
  • 6/28/2017 - 7 years ago
    25 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA
  • 6/27/2017 - 7 years ago
    24 - EXTENSION 2 GRANTED Type: EX2G
  • 6/13/2017 - 7 years ago
    23 - EXTENSION 2 FILED Type: EXT2
  • 6/24/2017 - 7 years ago
    22 - CASE ASSIGNED TO INTENT TO USE PARALEGAL Type: AITU
  • 6/21/2017 - 7 years ago
    21 - AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP Type: ASGN
  • 6/13/2017 - 7 years ago
    20 - TEAS EXTENSION RECEIVED Type: EEXT
  • 1/31/2017 - 7 years ago
    19 - TEAS CHANGE OF CORRESPONDENCE RECEIVED Type: TCCA
  • 1/5/2017 - 7 years ago
    18 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA
  • 1/3/2017 - 7 years ago
    17 - EXTENSION 1 GRANTED Type: EX1G
  • 1/3/2017 - 7 years ago
    16 - EXTENSION 1 FILED Type: EXT1
  • 1/3/2017 - 7 years ago
    15 - TEAS EXTENSION RECEIVED Type: EEXT
  • 7/26/2016 - 8 years ago
    14 - NOA E-MAILED - SOU REQUIRED FROM APPLICANT Type: NOAM
  • 5/31/2016 - 8 years ago
    13 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 5/31/2016 - 8 years ago
    12 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 5/11/2016 - 8 years ago
    11 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 4/28/2016 - 8 years ago
    10 - LAW OFFICE PUBLICATION REVIEW COMPLETED Type: PREV
  • 4/21/2016 - 8 years ago
    9 - ASSIGNED TO LIE Type: ALIE
  • 4/8/2016 - 8 years ago
    8 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 4/5/2016 - 8 years ago
    7 - EXAMINER'S AMENDMENT ENTERED Type: XAEC
  • 4/5/2016 - 8 years ago
    6 - NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Type: GNEN
  • 4/5/2016 - 8 years ago
    5 - EXAMINERS AMENDMENT E-MAILED Type: GNEA
  • 4/5/2016 - 8 years ago
    4 - EXAMINERS AMENDMENT -WRITTEN Type: CNEA
  • 3/30/2016 - 8 years ago
    3 - ASSIGNED TO EXAMINER Type: DOCK
  • 12/18/2015 - 8 years ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM Type: NWOS
  • 12/17/2015 - 8 years ago
    1 - NEW APPLICATION ENTERED IN TRAM Type: NWAP